Carcinosarcoma with Choriocarcinomatous and Osteosarcomatous Differentiation in a Patient with Juvenile Polyposis

Rafael Parra-Medina1, Patricia López Correa1, Julian Jiménez Moreno2

  • 1Department of Pathology, Hospital Infantil de San José , Bogotá, Colombia ; Fundación Universitaria de Ciencias de la Salud , Bogotá, Colombia.

Rare Tumors
|October 27, 2015
PubMed

Insights

Juvenile polyposis syndrome (JPS), a rare genetic disorder, typically causes hamartomatous polyps. This case highlights a unique JPS association with a complex abdominal tumor containing adenocarcinoma, osteosarcoma, and choriocarcinoma.

Area of Science:

  • Oncology
  • Gastroenterology
  • Genetics

Background:

  • Juvenile polyposis syndrome (JPS) is an autosomal dominant condition characterized by hamartomatous polyps in the gastrointestinal tract.
  • Patients with JPS have an elevated risk of developing colorectal adenocarcinoma.
  • The occurrence of extracolonic tumors in JPS is rare, and complex tumor histology is exceptionally uncommon.

Observation:

  • A 12-year-old boy diagnosed with JPS presented with an abdominal tumor.
  • Histopathological examination revealed a complex tumor with components of adenocarcinoma, osteosarcoma, and choriocarcinoma.

Findings:

  • Immunohistochemical analysis of the tumor was positive for AE1/AE3, CK7, HCG, and SALL4.
  • This specific combination of tumor types (adenocarcinoma, osteosarcoma, choriocarcinoma) associated with JPS represents a novel and previously unreported finding.

Implications:

  • This case expands the known spectrum of malignancies associated with JPS.
  • Highlights the importance of comprehensive histopathological evaluation in JPS patients presenting with tumors.
  • Suggests potential for complex and rare tumor presentations in individuals with genetic predispositions.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K